Paediatric data management support
Participation in clinical (human) trials is essential to improve the survival of children with cancer. Our team continues to collaborate internationally with study groups from Europe and the USA to look for ways to enhance care and provide the most up to date treatment.
Knowledge about the various cancers affecting children is expanding rapidly with vastly improved techniques available to work out the inner functioning of these cancers. Whilst traditional chemotherapy and radiotherapy remain the backbone of many of our treatments, we are about to enter an exciting new time for novel treatments that may be more targeted in their activity. Access to these new treatments will be via clinical trial participation - so it is vital that our trial programme continues.
What we aim to achieve
We aim to continue to enrol children with cancer on clinical trials – such that they have access to the most up to date therapy – and continue to collect information about clinical outcomes that may inform future research
Our next steps and milestones
Our next steps include involvement in projects that may offer personalised treatment to patients who relapse and continue to incorporate tumour biology into decision making regarding upfront therapy. This is best achieved as part of ongoing clinical trials.
What motivates me
We are motivated by our desire to cure cancer in children. In doing so, we also wish to ensure the quality of life for survivors. Life expectancy and quality of life assumes a new level of importance when considering paediatric cancer.
My message to supporters
We are entering an exciting new phase where important advances are being made in several areas. Molecular diagnostics are assuming an increasing importance in identifying tumour types and in identifying aberrant tumour biology. New therapeutics targeting tumour pathways (many of which are not chemotherapy) may offer ever improving cure rates. We are on the brink of the provision of personalised medicine. So this is a very exciting time to be involved in research.